Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group

Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group

Leukemia advance online publication, September 15 2017.
doi:10.1038/leu.2017.246

Authors: M A Hoechstetter, R Busch, B Eichhorst, A Bühler, D Winkler, M J Eckart, U Vehling-Kaiser, H Schimke, U Jäger, H J Hurtz, G Hopfinger, F Hartmann, H Fuss, W Abenhardt, I Blau, W Freier, L Müller, M Goebeler, C M Wendtner, J Bahlo, K Fischer, M Bentz, B Emmerich, H Döhner, M Hallek & S Stilgenbauer

Source: Leukemia - September 15, 2017 Category: Hematology Authors: M A Hoechstetter R Busch B Eichhorst A B ü hler D Winkler M J Eckart U Vehling-Kaiser H Schimke U J ä ger H J Hurtz G Hopfinger F Hartmann H Fuss W Abenhardt I Blau W Freier L M ü ller M Goebeler C M Wendtner J Bahlo K Fischer M Bentz B Emmerich H D ö Source Type: research